Dr Bruce Mazer has been named interim executive director and chief scientific officer of the Research Institute of the McGill University Health Centre (RI-MUHC), effective October 1. Mazer has served as deputy executive director/deputy CSO of the RI-MUHC and head of Child Health Research at the Montreal Children's Hospital of the MUHC (MCH-MUHC) since April 2015. He is also a professor of pediatrics in the Faculty of Medicine at McGill Univ. A graduate of Columbia Univ, Mazer obtained his MD and training in pediatrics at McGill Univ. He replaces Dr Vassilios Papadopoulos who joined the Univ of Southern California October 1 as dean of its School of Pharmacy. During his nearly 10 years at McGill, Papadopoulos lead the Translational Research and Intervention across the Lifespan, which resulted in over $300 million in government grants to build a facility for clinical and biomedical research, the establishment of the Desjardins Centre for Advanced Training and a business development office to facilitate knowledge transfer and technology commercialization....